Programme

Overview: Artificial Intelligence is revolutionizing radiation therapy, but how can we ensure a safe, effective, and clinically validated implementation? In this must-attend session Barbara Jereczek introduces the ESTRO-AAPM AI guideline, a roadmap for developing, validating, and reporting AI models in clinical practice. Wouter van Elmpt will showcase applications in different domains. Discussed will be automation tasks such as AI-driven segmentation that are being introduced clinically. In addition, AI applications in the field clinical decision support systems and outcome prediction will be discussed, while debating whether clinics are ready to embrace these innovations. Interactive panel discussions will tackle key challenges, regulatory hurdles, and future perspectives. If you’re looking to integrate AI into your practice with confidence, this session is essential.

Overview: In this session we welcome our two multidisciplinary speakers from The Catharina Cancer Institute in Eindhoven, The Netherlands. During this session we will have the opportunity to learn first-hand how deep learning segmentation (DLS) has been implemented in their clinic, and how this process has changed their practice. Firstly, Clinical Physicist, Coen Hurkmans, will consider the motivation to implement DLS practices in a clinical environment. Drawing on evidence from the literature, he will highlight achievable results, common pitfalls, and strategies to mitigate errors in segmentation. He will also provide us with a comprehensive guide to evaluating the quality of segmentations within clinical workflows. Coen will also address the how to establish a multidisciplinary team to support the implementation phase of DLS. His talk will then be followed up by RTT colleague, Melissa Verdonk-van den Heuvel. Melissa will talk us through the practicalities of introducing DLS, using examples from various imaging technologies, including CBCT and MRI. She will also highlight the outcomes of testing protocols, and the ongoing quality assurance measures in place critical to the success of DLS. Finally, Melissa will discuss the evolving roles of radiation therapists (RTTs) in this changing landscape and explore potential future opportunities for advanced practice.

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.